Engineering a theranostic platform for synergistic hypoxia-responsive photodynamic therapy and chemotherapy

Lin, 2018, Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy, Chem. Soc. Rev., 47, 1938, 10.1039/C7CS00471K

Izci, 2021, The use of alternative strategies for enhanced nanoparticle delivery to solid tumors, Chem. Rev., 121, 1746, 10.1021/acs.chemrev.0c00779

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71, 209, 10.3322/caac.21660

Li, 2020, Aminopeptidase N activatable fluorescent probe for tracking metastatic cancer and image-guided surgery via in situ spraying, J. Am. Chem. Soc., 142, 6381, 10.1021/jacs.0c01365

Sharma, 2019, Hypoxia-targeted drug delivery, Chem. Soc. Rev., 48, 771, 10.1039/C8CS00304A

Ahmad, 2019, Codoping enhanced radioluminescence of nanoscintillators for X-ray-activated synergistic cancer therapy and prognosis using metabolomics, ACS Nano, 13, 10419, 10.1021/acsnano.9b04213

He, 2020, Semiconducting polycomplex nanoparticles for photothermal ferrotherapy of cancer, Angew. Chem. Int. Ed., 59, 10633, 10.1002/anie.202003004

Liang, 2020, Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy, Adv. Mater., 32, e2003214, 10.1002/adma.202003214

Xing, 2021, Advances and perspectives in organic sonosensitizers for sonodynamic therapy, Coord. Chem. Rev., 445, 214087, 10.1016/j.ccr.2021.214087

Tang, 2021, Biomedicine meets Fenton chemistry, Chem. Rev., 121, 1981, 10.1021/acs.chemrev.0c00977

Mangraviti, 2015, Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo, ACS Nano, 9, 1236, 10.1021/nn504905q

Sang, 2019, Recent advances in nanomaterial-based synergistic combination cancer immunotherapy, Chem. Soc. Rev., 48, 3771, 10.1039/C8CS00896E

Yang, 2019, Reactive oxygen species (ROS)-based nanomedicine, Chem. Rev., 119, 4881, 10.1021/acs.chemrev.8b00626

Zhao, 2019, Versatile types of organic/inorganic nanohybrids: from strategic design to biomedical applications, Chem. Rev., 119, 1666, 10.1021/acs.chemrev.8b00401

Zhang, 2020, An all-round athlete on the track of phototheranostics: subtly regulating the balance between radiative and nonradiative decays for multimodal imaging-guided synergistic therapy, Adv. Mater., 32, e2003210, 10.1002/adma.202003210

Fan, 2016, Overcoming the Achilles' heel of photodynamic therapy, Chem. Soc. Rev., 45, 6488, 10.1039/C6CS00616G

Du, 2021, Enhanced photodynamic therapy for overcoming tumor hypoxia: from microenvironment regulation to photosensitizer innovation, Coord. Chem. Rev., 427, 213604, 10.1016/j.ccr.2020.213604

Xie, 2021, Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies, Chem. Soc. Rev., 50, 9152, 10.1039/D0CS01370F

Zhao, 2021, Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application, Chem. Soc. Rev., 50, 4185, 10.1039/D0CS00173B

Li, 2020, Clinical development and potential of photothermal and photodynamic therapies for cancer, Nat. Rev. Clin. Oncol., 17, 657, 10.1038/s41571-020-0410-2

Liu, 2021, Recent advances of AIE light-up probes for photodynamic therapy, Chem. Sci., 12, 6488, 10.1039/D1SC00045D

Celli, 2010, Imaging and photodynamic therapy: mechanisms, monitoring, and optimization, Chem. Rev., 110, 2795, 10.1021/cr900300p

Nguyen, 2021, Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer, Acc. Chem. Res., 54, 207, 10.1021/acs.accounts.0c00606

Huang, 2021, Photodynamic therapy for hypoxic tumors: advances and perspectives, Coord. Chem. Rev., 438, 213888, 10.1016/j.ccr.2021.213888

Cheng, 2015, Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy, Nat. Commun., 6, 8785, 10.1038/ncomms9785

Li, 2018, Innovative strategies for hypoxic-tumor photodynamic therapy, Angew. Chem. Int. Ed., 57, 11522, 10.1002/anie.201805138

Won, 2021, An ethacrynic acid-brominated BODIPY photosensitizer (EA-BPS) construct enhances the lethality of reactive oxygen species in hypoxic tumor-targeted photodynamic therapy, Angew. Chem. Int. Ed., 60, 3196, 10.1002/anie.202012687

Liu, 2017, A mitochondrial-targeted prodrug for NIR imaging guided and synergetic NIR photodynamic-chemo cancer therapy, Chem. Sci., 8, 7689, 10.1039/C7SC03454G

Lee, 2022, Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles, Bioact. Mater., 8, 20, 10.1016/j.bioactmat.2021.06.019

Zhang, 2021, Cascade drug-release strategy for enhanced anticancer therapy, Matter, 4, 26, 10.1016/j.matt.2020.10.002

Chen, 2016, Tumor-triggered drug release with tumor-targeted accumulation and elevated drug retention to overcome multidrug resistance, Chem. Mater., 28, 6742, 10.1021/acs.chemmater.6b03236

Yang, 2021, NIR-controlled treatment of multidrug-resistant tumor cells by mesoporous silica capsules containing gold nanorods and doxorubicin, ACS Appl. Mater. Inter., 13, 14894, 10.1021/acsami.0c23073

Kim, 2021, A small molecule strategy for targeting cancer stem cells in hypoxic microenvironments and preventing tumorigenesis, J. Am. Chem. Soc., 143, 14115, 10.1021/jacs.1c03875

Xue, 2021, Stimulus-cleavable chemistry in the field of controlled drug delivery, Chem. Soc. Rev., 50, 4872, 10.1039/D0CS01061H

Wu, 2014, In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug, J. Am. Chem. Soc., 136, 3579, 10.1021/ja412380j

Li, 2017, A self-immolative and DT-diaphorase-activatable prodrug for drug-release tracking and therapy, J. Mater. Chem. B, 5, 2635, 10.1039/C7TB00266A

Wei, 2019, Release of amino- or carboxy-containing compounds triggered by HOCl: application for imaging and drug design, Angew. Chem. Int. Ed., 58, 4547, 10.1002/anie.201813648

Verwilst, 2017, Reconsidering azobenzene as a component of small-molecule hypoxia-mediated cancer drugs: a theranostic case study, Biomaterials, 115, 104, 10.1016/j.biomaterials.2016.11.023

Lee, 2018, Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics, Chem. Soc. Rev., 47, 28, 10.1039/C7CS00557A

Piao, 2017, Development of an azo-based photosensitizer activated under mild hypoxia for photodynamic therapy, J. Am. Chem. Soc., 139, 13713, 10.1021/jacs.7b05019

Tian, 2018, Near-infrared fluorescent probes for hypoxia detection via joint regulated enzymes: design, synthesis, and application in living cells and mice, Anal. Chem., 90, 13759, 10.1021/acs.analchem.8b04249

Tian, 2019, In-situ imaging of azoreductase activity in the acute and chronic ulcerative colitis mice by a near-infrared fluorescent probe, Anal. Chem., 91, 10901, 10.1021/acs.analchem.9b02857

Wang, 2020, Activatable two-photon near-infrared fluorescent probe tailored toward peroxynitrite in vivo imaging in tumors, Anal. Chem., 92, 13305, 10.1021/acs.analchem.0c02587

Xiong, 2020, Visualizing peroxynitrite in microvessels of the brain with stroke using an engineered highly specific fluorescent probe, ACS Sens., 5, 3237, 10.1021/acssensors.0c01555

Juvekar, 2020, An azo dye for photodynamic therapy that is activated selectively by two-photon excitation, Chem. Sci., 12, 427, 10.1039/D0SC05686C

Zhao, 2020, Precisely traceable drug delivery of azoreductase-responsive prodrug for colon targeting via multimodal imaging, Anal. Chem., 92, 9039, 10.1021/acs.analchem.0c01220

Ding, 2019, Azo-based near-infrared fluorescent theranostic probe for tracking hypoxia-activated cancer chemotherapy in vivo, Chem. Commun., 55, 13172, 10.1039/C9CC06727B

Feng, 2017, Near-infrared fluorescent turn-on probe with a remarkable large stokes shift for imaging selenocysteine in living cells and animals, Anal. Chem., 89, 6106, 10.1021/acs.analchem.7b00824

Ren, 2018, A general method to increase Stokes shift by introducing alternating vibronic structures, J. Am. Chem. Soc., 140, 7716, 10.1021/jacs.8b04404

Hettie, 2019, Near-infrared fluorescent Rosol dye tailored toward lymphatic mapping applications, Anal. Chem., 91, 3110, 10.1021/acs.analchem.8b05709

Huang, 2019, An activatable near-infrared chromophore for multispectral optoacoustic imaging of tumor hypoxia and for tumor inhibition, Theranostics, 9, 7313, 10.7150/thno.36755

Eom, 2018, Biologically activatable azobenzene polymers targeted at drug delivery and imaging applications, Biomaterials, 185, 333, 10.1016/j.biomaterials.2018.09.020

Guo, 2013, A highly sensitive long-wavelength fluorescence probe for nitroreductase and hypoxia: selective detection and quantification, Chem. Commun., 49, 10820, 10.1039/c3cc45367g

Li, 2021, Cyanine conjugates in cancer theranostics, Bioact. Mater., 6, 794, 10.1016/j.bioactmat.2020.09.009

Mao, 2021, Biology-oriented design strategies of AIE theranostic probes, Matter, 4, 350, 10.1016/j.matt.2020.12.006

Sarma, 2018, Exciplex: an intermolecular charge-transfer approach for TADF, ACS Appl. Mater. Inter., 10, 19279, 10.1021/acsami.7b18318

Hu, 2019, Stimuli-responsive reversible switching of intersystem crossing in pure organic material for smart photodynamic therapy, Angew. Chem. Int. Ed., 58, 11105, 10.1002/anie.201905129

Shin, 2017, Development of an azoreductase-based reporter system with synthetic fluorogenic substrates, ACS Chem. Biol., 12, 558, 10.1021/acschembio.6b00852

Sarkar, 2021, A study on hypoxia susceptibility of organ tissues by fluorescence imaging with a ratiometric nitroreductase probe, ACS Sens., 6, 148, 10.1021/acssensors.0c01989

Xu, 2013, High selectivity imaging of nitroreductase using a near-infrared fluorescence probe in hypoxic tumor, Chem. Commun., 49, 2554, 10.1039/c3cc38980d

Ryan, 2019, Kinetics-based measurement of hypoxia in living cells and animals using an acetoxymethyl ester chemiluminescent probe, ACS Sens., 4, 1391, 10.1021/acssensors.9b00360

Zheng, 2017, Successively activatable ultrasensitive probe for imaging tumour acidity and hypoxia, Nat. Biomed. Eng., 1, 0057, 10.1038/s41551-017-0057

Huang, 2021, Magnetothermally triggered free-radical generation for deep-seated tumor treatment, Nano. Lett., 21, 2926, 10.1021/acs.nanolett.1c00009

Shin, 2021, Mitochondria-targeted nanotheranostic: harnessing single-laser-activated dual phototherapeutic processing for hypoxic tumor treatment, Matter, 4, 2508, 10.1016/j.matt.2021.05.022

Liew, 2021, Smart design of nanomaterials for mitochondria-targeted nanotherapeutics, Angew. Chem. Int. Ed., 60, 2232, 10.1002/anie.201915826

Zou, 2021, Single-molecule Förster resonance energy transfer-based photosensitizer for synergistic photodynamic/photothermal therapy, ACS Cent. Sci., 7, 327, 10.1021/acscentsci.0c01551

Wang, 2019, A mesoporous nanoenzyme derived from metal-organic frameworks with endogenous oxygen generation to alleviate tumor hypoxia for significantly enhanced photodynamic therapy, Adv. Mater., 31, e1901893, 10.1002/adma.201901893

Tang, 2020, Phosphorus science-oriented design and synthesis of multifunctional nanomaterials for biomedical applications, Matter, 2, 297, 10.1016/j.matt.2019.12.007

Xie, 2020, Black phosphorus-based photothermal therapy with aCD47-mediated immune checkpoint blockade for enhanced cancer immunotherapy, Light Sci. Appl., 9, 161, 10.1038/s41377-020-00388-3

Chen, 2020, Eradication of tumor growth by delivering novel photothermal selenium-coated tellurium nanoheterojunctions, Sci. Adv., 6, eaay6825, 10.1126/sciadv.aay6825

Ji, 2018, A novel top-down synthesis of ultrathin 2D boron nanosheets for multimodal imaging-guided cancer therapy, Adv. Mater., 30, 1803031, 10.1002/adma.201803031

Xie, 2020, Emerging combination strategies with phototherapy in cancer nanomedicine, Chem. Soc. Rev., 49, 8065, 10.1039/D0CS00215A